导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -0.45% | 582/1050 |
| 近一周 | -1.90% | 678/1104 |
| 近一月 | 1.44% | 47/1103 |
| 近一季 | -0.96% | 328/1092 |
| 近半年 | 1.58% | 405/1070 |
| 近一年 | 3.17% | 530/1018 |
| 近两年 | 46.96% | 529/926 |
| 近三年 | 30.92% | 393/834 |
| 成立以来 | 203.40% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-6.11% 864/1070 |
3.36% 646/1101 |
- - |
- - |
| 2025 | 18.80% 685/1065 |
-3.29% 965/1014 |
10.87% 83/1038 |
8.48% 872/1050 |
2.14% 292/1065 |
| 2024 | 24.80% 52/1011 |
4.34% 120/960 |
1.42% 219/983 |
17.08% 135/991 |
0.73% 281/1011 |
| 2023 | -21.72% 714/952 |
-4.85% 788/880 |
-3.02% 375/895 |
-5.06% 312/915 |
-10.65% 877/952 |
| 2022 | -21.74% 399/867 |
-17.15% 369/773 |
8.53% 324/806 |
-11.37% 332/845 |
-1.80% 527/867 |
| 2021 | 28.11% 85/740 |
0.11% 146/580 |
21.23% 146/659 |
1.63% 195/704 |
3.85% 266/740 |
| 2020 | 103.97% 23/554 |
2.44% 104/419 |
27.87% 146/466 |
16.49% 120/517 |
33.67% 29/554 |
| 2019 | 54.30% 121/410 |
28.15% 485/1149 |
3.31% 96/1231 |
7.12% 157/390 |
8.80% 206/410 |
| 2018 | -20.28% 86/349 |
- - |
- - |
- - |
-10.06% 298/1080 |
| 2017 | 11.99% 124/285 |
- - |
- - |
- - |
- - |
| 2016 | -5.84% 45/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 工银新金融股票A VS. 东吴新产业精选股票A(580008) |